Advertisement

Advertisement

ANIX Stock Latest News

Anixa Biosciences granted Australian patent for breast cancer vaccine

The FlyAnixa Biosciences granted Australian patent for breast cancer vaccine

Anixa Biosciences, Moffitt Cancer advance ovarian cancer CAR-T trial

PremiumThe Fly

Anixa Biosciences, Moffitt Cancer advance ovarian cancer CAR-T trial

2M ago

Anixa Biosciences assumed with a Buy at D. Boral Capital

PremiumThe Fly

Anixa Biosciences assumed with a Buy at D. Boral Capital

2M ago

Anixa Biosciences granted first Korean patent for breast cancer vaccine

PremiumThe Fly

Anixa Biosciences granted first Korean patent for breast cancer vaccine

2M ago

Anixa Biosciences reports results from two clinical-stage immunotherapy programs

PremiumThe Fly

Anixa Biosciences reports results from two clinical-stage immunotherapy programs

2M ago

Anixa Biosciences: CIPO issues Notice of Allowance for patent

PremiumThe FlyAnixa Biosciences: CIPO issues Notice of Allowance for patent

3M ago

Anixa Biosciences’ lira-cel shows positive survival data in ovarian cancer

The Fly

Anixa Biosciences’ lira-cel shows positive survival data in ovarian cancer

4M ago

Anixa Biosciences awarded patent for breast cancer vaccine in Mexico

The Fly

Anixa Biosciences awarded patent for breast cancer vaccine in Mexico

4M ago

Anixa Biosciences announces agreement with Cytovance Biologics

PremiumThe Fly

Anixa Biosciences announces agreement with Cytovance Biologics

5M ago

Anixa Biosciences Shareholders Back Board and Compensation

PremiumCompany Announcements

Anixa Biosciences Shareholders Back Board and Compensation

6M ago

Anixa Biosciences says Korean MOIP issues Notice of Allowance for new patent

PremiumThe Fly

Anixa Biosciences says Korean MOIP issues Notice of Allowance for new patent

6M ago

Anixa Advances Ovarian Cancer CAR-T With Higher Dosing

PremiumCompany Announcements

Anixa Advances Ovarian Cancer CAR-T With Higher Dosing

7M ago

Anixa provides update on Phase 1 ovarian cancer CAR-T clinical trial

PremiumThe FlyAnixa provides update on Phase 1 ovarian cancer CAR-T clinical trial

7M ago

Anixa Biosciences receives USAN Council approval for novel CAR-T therapy name

The Fly

Anixa Biosciences receives USAN Council approval for novel CAR-T therapy name

7M ago

Anixa Biosciences granted patent for breast cancer vaccine technology in Mexico

The Fly

Anixa Biosciences granted patent for breast cancer vaccine technology in Mexico

7M ago

Anixa announces transfer of IND for breast cancer vaccine from Cleveland Clinic

PremiumThe Fly

Anixa announces transfer of IND for breast cancer vaccine from Cleveland Clinic

9M ago

Anixa Biosciences Reports Positive Phase 1 Trial Results

PremiumCompany Announcements

Anixa Biosciences Reports Positive Phase 1 Trial Results

9M ago

Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial

PremiumThe Fly

Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial

9M ago

Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name

PremiumThe Fly

Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name

10M ago

Anixa Biosciences awarded patent covering breast cancer vaccine technology

PremiumThe FlyAnixa Biosciences awarded patent covering breast cancer vaccine technology

10M ago

Anixa Biosciences executes data transfer with Cleveland Clinic

The Fly

Anixa Biosciences executes data transfer with Cleveland Clinic

10M ago

Anixa awarded patent in China covering breast cancer vaccine technology

The Fly

Anixa awarded patent in China covering breast cancer vaccine technology

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >